Marium A Abo-Dola1, Mohamed F Lutfi2. 1. Department of Pharmacology, Faculty of Medicine and Health Sciences, Al-neelain University, Khartoum, Sudan Email: mariamawad2009@yahoo.com. 2. Department of Physiology, Faculty of Medicine and Health Sciences, Al-Neelain University, Khartoum, Sudan.
Abstract
BACKGROUND: There were no studies on the anti-inflammatory activity of Euphorbia aegyptiaca, though it is commonly used by Sudanese herbalists in the treatment of rheumatoid arthritis. OBJECTIVES: To determine phytochemical constituents of Euphorbia aegyptiacaTo investigate the anti-inflammatory activity of Euphorbia aegyptiaca in rats. METHODOLOGY: Plant material was extracted by ethanol and phytochemical screening was done according to standard methods. The thickness of Albino rats' paws were measured before injection of 0.1 ml of 1% formalin in the sub planter region and then, 1, 2, 3, 4 and 24 hours after oral dose of ethanolic extract of Euphorbia aegyptiaca at a rate of 400mg/kg, 800mg/kg, indomethacin (5mg/kg) and normal saline (5ml/kg). Edema inhibition percentage (EI%) and mean paw thickness (MPT) were measured in the different groups and compared using appropriate statistical methods. RESULTS: The phytochemical screening revealed the presence of saponins, cumarins, flavonoids, tannins, sterols, triterpenes, and absence of alkaloids, anthraquinones glycosides and cyanogenic glycosides. The mean of EI% of rats treated with indomethacin at a dose of 5 mg/kg over different time intervals (64.0%) was significantly lower compared to those treated with Euphorbia aegyptiaca at a dose of 800 mg/kg (75.0%, P< 0.001), but higher compared to rats treated at higher dose of 400 mg/kg (57.4%, P< 0.001). In contrast, MPT of rats treated with indomethacin at a dose of 5 mg/kg (6.5±1.1 mm) was significantly higher compared to those treated with Euphorbia aegyptiaca at a dose of 800 mg/kg (6.1±.7 mm, P< 0.001) as well as 400 mg/kg (5.9±.5, P< 0.001). CONCLUSION: Euphorbia aegyptiaca ethanolic extract has a sustained dose-dependent anti-inflammatory activity.
BACKGROUND: There were no studies on the anti-inflammatory activity of Euphorbia aegyptiaca, though it is commonly used by Sudanese herbalists in the treatment of rheumatoid arthritis. OBJECTIVES: To determine phytochemical constituents of Euphorbia aegyptiacaTo investigate the anti-inflammatory activity of Euphorbia aegyptiaca in rats. METHODOLOGY: Plant material was extracted by ethanol and phytochemical screening was done according to standard methods. The thickness of Albino rats' paws were measured before injection of 0.1 ml of 1% formalin in the sub planter region and then, 1, 2, 3, 4 and 24 hours after oral dose of ethanolic extract of Euphorbia aegyptiaca at a rate of 400mg/kg, 800mg/kg, indomethacin (5mg/kg) and normal saline (5ml/kg). Edema inhibition percentage (EI%) and mean paw thickness (MPT) were measured in the different groups and compared using appropriate statistical methods. RESULTS: The phytochemical screening revealed the presence of saponins, cumarins, flavonoids, tannins, sterols, triterpenes, and absence of alkaloids, anthraquinones glycosides and cyanogenic glycosides. The mean of EI% of rats treated with indomethacin at a dose of 5 mg/kg over different time intervals (64.0%) was significantly lower compared to those treated with Euphorbia aegyptiaca at a dose of 800 mg/kg (75.0%, P< 0.001), but higher compared to rats treated at higher dose of 400 mg/kg (57.4%, P< 0.001). In contrast, MPT of rats treated with indomethacin at a dose of 5 mg/kg (6.5±1.1 mm) was significantly higher compared to those treated with Euphorbia aegyptiaca at a dose of 800 mg/kg (6.1±.7 mm, P< 0.001) as well as 400 mg/kg (5.9±.5, P< 0.001). CONCLUSION: Euphorbia aegyptiaca ethanolic extract has a sustained dose-dependent anti-inflammatory activity.
Entities:
Keywords:
Euphorbia aegyptiaca; anti-inflammatory; edema; indomethacin
Authors: Doris S Llanes-Coronel; Laura Y Gámez-Díaz; Leidy P Suarez-Quintero; Lady J Páez; Fernando Torres; Fernando Echeverri; Alicia Ponte-Sucre; Pablo J Patiño; Claudia M Trujillo-Vargas Journal: Immunopharmacol Immunotoxicol Date: 2010-07-29 Impact factor: 2.730
Authors: Bui Thi Thuy Luyen; Bui Huu Tai; Nguyen Phuong Thao; Kim Ji Eun; Ji Yun Cha; Ming Jie Xin; Young Mi Lee; Young Ho Kim Journal: Bioorg Med Chem Lett Date: 2014-03-15 Impact factor: 2.823